Photon-Counting Detector CT to Detect Bone Quality

Overview

About this study

The purpose of this study is to determine the ability of photon-counting detector CT (PCD-CT) to detect bone quality changes in osteoporotic patients undergoing pharmacologic therapy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult patients 18 to 99 years of age
Patients with osteoporosis diagnosed by clinical DXA and necessitating bone anabolic medication
Patients who have previously undergone pharmacologic therapy for osteoporosis.
Patients who are able and willing to sign the informed consent.

Exclusion Criteria:

Minors less than 18 years old
Patients with metal implants, cement, or bone grafts in vertebral bodies that would be analyzed
Patient unable to provide written informed consent
Pregnancy

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/10/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Francis Baffour, M.D.	Open for enrollment	Contact information: Francis Baffour M.D. Baffour.Francis@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Francis Baffour, M.D.

Open for enrollment

Contact information:

Francis Baffour M.D.

Baffour.Francis@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials